ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 239 filers reported holding ARRAY BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $282,000 | +73.0% | 11,553 | +0.9% | 0.29% | +33.6% |
| Q4 2018 | $163,000 | -6.3% | 11,448 | +0.0% | 0.22% | +35.8% |
| Q3 2018 | $174,000 | -57.1% | 11,447 | -52.7% | 0.16% | -53.4% |
| Q2 2018 | $406,000 | +88.0% | 24,214 | +82.9% | 0.35% | +68.1% |
| Q1 2018 | $216,000 | +21500.0% | 13,236 | +18283.3% | 0.21% | +20600.0% |
| Q4 2017 | $1,000 | 0.0% | 72 | -49.3% | 0.00% | 0.0% |
| Q1 2017 | $1,000 | 0.0% | 142 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,000 | -95.5% | 142 | -97.1% | 0.00% | -92.3% |
| Q2 2013 | $22,000 | – | 4,837 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |